FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984912591> ?p ?o ?g. }

• W2984912591 endingPage "553" @default.
• W2984912591 startingPage "541" @default.
• W2984912591 abstract "In the 2016, WHO classification of tumors of the central nervous system, isocitrate dehydrogenase (IDH) mutation is a main classifier for lower grade astrocytomas and IDH-mutated astrocytomas is now regarded as a single group with longer survival. However, the molecular and clinical heterogeneity among IDH mutant lower grade (WHO Grades II/III) astrocytomas have only rarely been investigated. In this study, we recruited 160 IDH mutant lower grade (WHO Grades II/III) astrocytomas, and examined PDGFRA amplification, CDKN2A deletion and CDK4 amplification by FISH analysis, TERT promoter mutation by Sanger sequencing and ATRX loss and p53 expression by immunohistochemistry. We identified PDGFRA amplification, CDKN2A homozygous deletion and CDK4 amplification in 18.8%, 15.0% and 18.1% of our cohort respectively, and these alterations occurred in a mutually exclusive fashion. PDGFRA amplification was associated with shorter PFS (P = 0.0003) and OS (P < 0.0001). In tumors without PDGFRA amplification, CDKN2A homozygous deletion or CDK4 amplification was associated with a shorter OS (P = 0.035). Tumors were divided into three risk groups based on the presence of molecular alterations: high risk (PDGFRA amplification), intermediate risk (CDKN2A deletion or CDK4 amplification) and low risk (neither CDKN2A deletion and CDK4 amplification nor PDGFRA amplification). These three risk groups were significantly different in overall survival with mean survivals of 40.5, 62.9 and 71.5 months. The high-risk group also demonstrated a shorter PFS compared to intermediate- (P = 0.036) and low-risk (P < 0.0001) groups. One limitation of this study is the relatively short follow-up period, a common confounding factor for studies on low-grade tumors. Our data illustrate that IDH mutant lower grade astrocytomas is not a homogeneous group and should be molecularly stratified for risk." @default.
• W2984912591 created "2019-11-22" @default.
• W2984912591 creator A5006836966 @default.
• W2984912591 creator A5010813275 @default.
• W2984912591 creator A5017491967 @default.
• W2984912591 creator A5019896088 @default.
• W2984912591 creator A5022662736 @default.
• W2984912591 creator A5023420401 @default.
• W2984912591 creator A5029912336 @default.
• W2984912591 creator A5039958135 @default.
• W2984912591 creator A5047949662 @default.
• W2984912591 creator A5056724651 @default.
• W2984912591 creator A5057927752 @default.
• W2984912591 creator A5059485677 @default.
• W2984912591 creator A5064530138 @default.
• W2984912591 creator A5065549183 @default.
• W2984912591 creator A5069813497 @default.
• W2984912591 creator A5078264358 @default.
• W2984912591 creator A5084496916 @default.
• W2984912591 creator A5090893217 @default.
• W2984912591 date "2019-12-03" @default.
• W2984912591 modified "2023-10-17" @default.
• W2984912591 title "IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations" @default.
• W2984912591 cites W1522705466 @default.
• W2984912591 cites W1554558913 @default.
• W2984912591 cites W1793758766 @default.
• W2984912591 cites W1812256879 @default.
• W2984912591 cites W1836650925 @default.
• W2984912591 cites W1893134211 @default.
• W2984912591 cites W1952429608 @default.
• W2984912591 cites W1986092833 @default.
• W2984912591 cites W1988756388 @default.
• W2984912591 cites W2028906953 @default.
• W2984912591 cites W2048796627 @default.
• W2984912591 cites W2052681965 @default.
• W2984912591 cites W2079949890 @default.
• W2984912591 cites W2104917184 @default.
• W2984912591 cites W2107007091 @default.
• W2984912591 cites W2126817554 @default.
• W2984912591 cites W2129554457 @default.
• W2984912591 cites W2143078369 @default.
• W2984912591 cites W2151336775 @default.
• W2984912591 cites W2154313451 @default.
• W2984912591 cites W2154974088 @default.
• W2984912591 cites W2158501128 @default.
• W2984912591 cites W2161289668 @default.
• W2984912591 cites W2204869748 @default.
• W2984912591 cites W2263206910 @default.
• W2984912591 cites W228600387 @default.
• W2984912591 cites W2296309800 @default.
• W2984912591 cites W2366536035 @default.
• W2984912591 cites W2608192684 @default.
• W2984912591 cites W2737907665 @default.
• W2984912591 cites W2739147644 @default.
• W2984912591 cites W2751210549 @default.
• W2984912591 cites W2802818144 @default.
• W2984912591 cites W2803325987 @default.
• W2984912591 cites W2808348548 @default.
• W2984912591 cites W2894102714 @default.
• W2984912591 cites W571060166 @default.
• W2984912591 doi "https://doi.org/10.1111/bpa.12801" @default.
• W2984912591 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8018138" @default.
• W2984912591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31733156" @default.
• W2984912591 hasPublicationYear "2019" @default.
• W2984912591 type Work @default.
• W2984912591 sameAs 2984912591 @default.
• W2984912591 citedByCount "65" @default.
• W2984912591 countsByYear W29849125912020 @default.
• W2984912591 countsByYear W29849125912021 @default.
• W2984912591 countsByYear W29849125912022 @default.
• W2984912591 countsByYear W29849125912023 @default.
• W2984912591 crossrefType "journal-article" @default.
• W2984912591 hasAuthorship W2984912591A5006836966 @default.
• W2984912591 hasAuthorship W2984912591A5010813275 @default.
• W2984912591 hasAuthorship W2984912591A5017491967 @default.
• W2984912591 hasAuthorship W2984912591A5019896088 @default.
• W2984912591 hasAuthorship W2984912591A5022662736 @default.
• W2984912591 hasAuthorship W2984912591A5023420401 @default.
• W2984912591 hasAuthorship W2984912591A5029912336 @default.
• W2984912591 hasAuthorship W2984912591A5039958135 @default.
• W2984912591 hasAuthorship W2984912591A5047949662 @default.
• W2984912591 hasAuthorship W2984912591A5056724651 @default.
• W2984912591 hasAuthorship W2984912591A5057927752 @default.
• W2984912591 hasAuthorship W2984912591A5059485677 @default.
• W2984912591 hasAuthorship W2984912591A5064530138 @default.
• W2984912591 hasAuthorship W2984912591A5065549183 @default.
• W2984912591 hasAuthorship W2984912591A5069813497 @default.
• W2984912591 hasAuthorship W2984912591A5078264358 @default.
• W2984912591 hasAuthorship W2984912591A5084496916 @default.
• W2984912591 hasAuthorship W2984912591A5090893217 @default.
• W2984912591 hasBestOaLocation W29849125911 @default.
• W2984912591 hasConcept C104317684 @default.
• W2984912591 hasConcept C121608353 @default.
• W2984912591 hasConcept C126322002 @default.
• W2984912591 hasConcept C143065580 @default.
• W2984912591 hasConcept C143998085 @default.
• W2984912591 hasConcept C16930146 @default.
• W2984912591 hasConcept C2775922572 @default.

• next